Skip to content

Study of absorption enhancing effect of fat soluble vitamins by fermented milk in human subjects.

Study of absorption enhancing effect of fat soluble vitamins by fermented milk in human subjects. - Study of absorption enhancing effect of fat soluble vitamins by fermented milk in human subjects.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000055025
Enrollment
20
Registered
2024-07-22
Start date
2024-09-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Subjects receive a single dose of fat soluble vitamins + water. After the washout period (13 days or more), subjects receive a single dose of fat soluble vitamins + fermented milk. Subjects receive a

Sponsors

Meiji Holdings Co., Ltd.
Lead Sponsor
Meiji Co., Ltd., CPCC Company Limited, Chiyoda Paramedical Care Clinic
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Subjects giving written informed consent 2) Males aged 20 to 35 years old when consent acquisition 3) Subjects whose body mass index (BMI) is from 18.5 kg/m2 to 25.0 kg/m2

Exclusion criteria

Exclusion criteria: 1) Subjects who routinely use pharmaceuticals, quasi-drugs, dietary supplement, and consume food for specified health uses, supplements containing fat soluble vitamins more than two days per week 2) Subjects who have chronic diseases necessitating treatments and/or medications 3) Subjects who have abnormal lipid metabolism, glucose metabolism, liver function, or kidney function 4) Subjects who received digestive surgical procedures 5) habitual smokers 6) Subjects who participate in other clinical trials within the past month or have plans to participate in other clinical trials during this study period 7) Subjects who have food allergy 8) Subjects who is conscious of being prone to diarrhea from dairy products 9) Subjects who donate 200 mL of blood within a month, or 400 mL of blood within three month 10) Subjects who determine ineligible by the principal investigator or sub-investigator

Design outcomes

Primary

MeasureTime frame
Plasma vitamin E concentration

Secondary

MeasureTime frame
Plasma vitamin A, D, K concentration and their metabolites

Countries

Japan

Contacts

Public ContactMasashi Morifuji

Meiji Holdings Co., Ltd. Wellness science labs.

masashi.morifuji@meiji.com042-632-5846

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026